Background information regarding Univec's (UNVC) t
Post# of 1230
Owings Mills, Maryland —January 17, 2012– Univec, Inc. (UNVC) a specialty pharmaceutical company, announces it has entered into the transdermal patch marketplace with the provision of Nicotine Replacement Therapy patches.
David L. Dalton, President and CEO of Univec stated. “We are delighted to continue making progress in our new business model. The National Drug Codes received from the FDA allows Univec to builds it’s own brand of products. The Transdermal patch can be used for different drug delivery systems. It is a foundation to build and grow the company on some of our existing markets.
Univec's Transdermal Delivery system enhances bioavailability, minimizes pharmaco-kinetic peaks, improves tolerability and dosing, increases patient compliance, and continuous delivery.
https://www.businesswire.com/news/home/201207...ment-Patch
https://www.otcmarkets.com/stock/UNVC/news/UN...71&b=y